Evidence map›Paper›PMID 36358469›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Antioxidant Potential of Resveratrol as the Result of Radiation Exposition.

Natalia Rosiak, Judyta Cielecka-Piontek, Robert Skibiński, Kornelia Lewandowska, Waldemar Bednarski, Przemysław Zalewski

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Myricetin Nanofibers as Amorphous Delivery System.Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalia RosiakDepartment of Pharmacognosy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0003-4722-6413
Judyta Cielecka-PiontekDepartment of Pharmacognosy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0003-0891-5419
Robert SkibińskiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.ORCID 0000-0001-8429-7515
Kornelia LewandowskaInstitute of Molecular Physics, Polish Academy of Sciences, Smoluchowskiego 17, 60-179 Poznań, Poland.ORCID 0000-0002-2063-7805
Waldemar BednarskiInstitute of Molecular Physics, Polish Academy of Sciences, Smoluchowskiego 17, 60-179 Poznań, Poland.ORCID 0000-0003-1956-7501
Przemysław ZalewskiDepartment of Pharmacognosy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0002-5116-9426

Funding

National Science Center 2020/37/B/NZ7/03975
6 · The paper itself

Abstract

The purpose of this study was to determine the effect of electron beam irradiation (EBI) at a dose of 25 kGy on the stability and antioxidant properties of resveratrol (RSV), a nutraceutical with clinically proven activity. The electron paramagnetic resonance (EPR) method was used to evaluate the concentration of free radicals after irradiation. Minor changes in chemical structure due to free radicals induced by EBI were confirmed by FTIR spectroscopy. HPLC and HPLC-MS analysis ruled out the appearance of degradation products after irradiation. In addition, HPLC analysis confirmed the absence of trans- to cis-resveratrol conversion. Changes in the antioxidant potential of RSV after irradiation were studied using DPPH, ABTS, CUPRAC, and FRAP techniques. It was confirmed that EBI favorably affected the antioxidant properties of tests based on the HAT mechanism (increase in DPPH and CUPRAC tests).

Indexed as

electron beam radiationelectron paramagnetic resonance (EPR)FT-IRstilbenoid

Identifiers

PMID36358469
PMCPMC9686677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.